Cambrex Karlskoga AB

Form 483 issued May 27, 2016 · Karlskoga, Sweden

Inspection
May 23 – May 27, 2016
Investigator
Nicholas L. Paulin
Observations
1
Pages
1
FEI number
3001686607

In short: On May 27, 2016, FDA issued a Form 483 with 1 observation to Cambrex Karlskoga AB in Karlskoga, Sweden (FEI 3001686607) after an inspection that ran May 23 – May 27, 2016. The investigator was Nicholas L. Paulin. Most observations concern quality system; the most-cited regulation is 21 CFR 211.198 (complaint files).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.198 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Your SOP 5533 titled, “Hantera kundreklamationer och produktreturer", (Revision 13), dated 2016-05-02 translated as "To Handle…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Cambrex Karlskoga AB?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected Cambrex Karlskoga AB?

Nicholas L. Paulin is named on this Form 483, for the inspection of May 23 – May 27, 2016. Each investigator has a profile showing what they cite most.

When was Cambrex Karlskoga AB inspected by FDA?

The inspection ran May 23 – May 27, 2016, and the Form 483 is dated May 27, 2016.

How do I get the full Form 483 for Cambrex Karlskoga AB?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free